Xenon Pharmaceuticals Inc (XENE)
41.13
+1.12
(+2.80%)
USD |
NASDAQ |
Apr 23, 16:00
41.07
-0.06
(-0.15%)
After-Hours: 20:00
Xenon Pharmaceuticals Shareholders Equity (Quarterly): 927.92M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 927.92M |
| September 30, 2023 | 636.59M |
| June 30, 2023 | 646.46M |
| March 31, 2023 | 686.94M |
| December 31, 2022 | 721.50M |
| September 30, 2022 | 753.12M |
| June 30, 2022 | 785.79M |
| March 31, 2022 | 541.85M |
| December 31, 2021 | 550.03M |
| September 30, 2021 | 248.94M |
| June 30, 2021 | 256.98M |
| March 31, 2021 | 276.28M |
| December 31, 2020 | 171.36M |
| September 30, 2020 | 182.02M |
| June 30, 2020 | 189.30M |
| March 31, 2020 | 187.98M |
| December 31, 2019 | 91.98M |
| September 30, 2019 | 74.56M |
| June 30, 2019 | 82.79M |
| March 31, 2019 | 92.31M |
| Date | Value |
|---|---|
| December 31, 2018 | 103.30M |
| September 30, 2018 | 111.16M |
| June 30, 2018 | 50.62M |
| March 31, 2018 | 28.50M |
| December 31, 2017 | 35.93M |
| September 30, 2017 | 43.30M |
| June 30, 2017 | 50.45M |
| March 31, 2017 | 57.20M |
| December 31, 2016 | 63.90M |
| September 30, 2016 | 69.31M |
| June 30, 2016 | 52.66M |
| March 31, 2016 | 58.16M |
| December 31, 2015 | 61.03M |
| September 30, 2015 | 64.46M |
| June 30, 2015 | 64.35M |
| March 31, 2015 | 68.97M |
| December 31, 2014 | 72.78M |
| September 30, 2014 | 34.98M |
| June 30, 2014 | 27.11M |
| December 31, 2013 | 24.12M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
74.56M
Minimum
Sep 2019
927.92M
Maximum
Dec 2023
421.70M
Average
276.28M
Median
Mar 2021
Shareholders Equity (Quarterly) Benchmarks
| Acasti Pharma Inc | 64.68M |
| Aurinia Pharmaceuticals Inc | 377.95M |
| Edesa Biotech Inc | 5.845M |
| Lexaria Bioscience Corp | 6.521M |
| ESSA Pharma Inc | 140.68M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 964.80M |
| Total Liabilities (Quarterly) | 36.88M |